Editas Medicine Inc. (EDIT)
1.19
0.06 (5.31%)
At close: Apr 02, 2025, 3:59 PM
1.12
-5.49%
After-hours: Apr 02, 2025, 07:59 PM EDT
Editas Medicine Income Statement
Financials in USD. Fiscal year
is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 |
| Revenue | 32.31M | 78.12M | 19.71M | 25.54M | 90.73M | 20.53M | 31.94M | 13.73M | 6.05M | 1.63M | n/a | n/a |
| Cost of Revenue | n/a | 177.65M | 6.34M | 5.05M | 158M | 96.9M | 90.65M | 83.16M | 56.98M | 18.85M | 5.07M | 1.59M |
| Gross Profit | 32.31M | -99.53M | 13.38M | 20.49M | -67.26M | -76.37M | -58.72M | -69.43M | -50.93M | -17.22M | -5.07M | -1.59M |
| Operating Income | -251.15M | -169.18M | -225.95M | -193.15M | -134.84M | -140.92M | -113.73M | -119.93M | -97.19M | -35.31M | -12.72M | -5.22M |
| Interest Income | 14.06M | 17.57M | 4.22M | 2.34M | 2.6M | 7.31M | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -237.09M | -153.22M | -220.43M | -192.5M | -115.98M | -133.75M | -109.95M | -120.32M | -97.18M | -72.9M | -13.69M | -5.27M |
| Net Income | -237.09M | -153.22M | -204.35M | -185.11M | -109.41M | -123.47M | -109.95M | -120.32M | -97.18M | -72.9M | -13.69M | -5.35M |
| Selling & General & Admin | 71.99M | 69.65M | 70.7M | 76.18M | 67.58M | 64.56M | 55.01M | 50.5M | 46.26M | 18.09M | 7.65M | 3.63M |
| Research & Development | 32.31M | 177.65M | 174.96M | 142.51M | 158M | 96.9M | 90.65M | 83.16M | 56.98M | 18.85M | 5.07M | 1.59M |
| Other Expenses | 179.16M | n/a | 1.29M | -1.7M | 16.26M | -137K | 328K | 587K | -57K | -37.45M | -928K | n/a |
| Operating Expenses | 283.47M | 247.3M | 245.66M | 218.69M | 225.57M | 161.45M | 145.66M | 133.66M | 103.24M | 36.94M | 12.72M | 3.68M |
| Interest Expense | n/a | n/a | 4.22M | n/a | n/a | n/a | n/a | 978K | n/a | 143K | 34K | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 283.47M | 247.3M | 245.66M | 218.69M | 225.57M | 161.45M | 145.66M | 133.66M | 103.24M | 36.94M | 12.72M | 5.27M |
| Income Tax | n/a | n/a | -16.08M | -7.39M | -6.56M | -10.28M | -3.12M | -1.12M | -1.32M | -37.77M | -894K | 75K |
| Shares Outstanding (Basic) | 82.34M | 75.97M | 68.66M | 67.62M | 58.61M | 49.98M | 47.1M | 40.32M | 32.22M | 35.7M | 15.44M | 300.48K |
| Shares Outstanding (Diluted) | 82.34M | 75.97M | 68.66M | 67.62M | 58.61M | 49.98M | 47.1M | 40.32M | 32.22M | 35.7M | 15.44M | 300.48K |
| EPS (Basic) | -2.88 | -2.02 | -2.98 | -2.74 | -1.87 | -2.47 | -2.33 | -2.98 | -3.02 | -2.04 | -0.89 | -17.8 |
| EPS (Diluted) | -2.88 | -2.02 | -2.98 | -2.74 | -1.87 | -2.47 | -2.33 | -2.98 | -3.02 | -2.04 | -0.89 | -17.8 |
| EBITDA | -233.11M | -163.12M | -219.61M | -188.09M | -130.88M | -138.09M | -110.47M | -116.66M | -96.07M | -72.29M | -13.49M | -5.22M |
| EBIT | -238.92M | -169.18M | -225.95M | -193.15M | -134.84M | -140.92M | -113.73M | -119.35M | -97.25M | -72.76M | -12.72M | -5.22M |
| Depreciation & Amortization | 5.81M | 6.06M | 6.34M | 5.05M | 3.96M | 2.83M | 3.25M | 2.68M | 1.2M | 471K | 157K | 3K |